1. Home
  2. ASTE vs ANNX Comparison

ASTE vs ANNX Comparison

Compare ASTE & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astec Industries Inc.

ASTE

Astec Industries Inc.

BUY

Current Price

$39.13

Market Cap

936.9M

Sector

Industrials

ML Signal

BUY

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.02

Market Cap

873.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTE
ANNX
Founded
1972
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
936.9M
873.3M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
ASTE
ANNX
Price
$39.13
$4.02
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
★ $67.25
$15.43
AVG Volume (30 Days)
145.2K
★ 3.2M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
★ 1.26%
N/A
EPS Growth
★ 784.21
N/A
EPS
★ 0.51
N/A
Revenue
N/A
N/A
Revenue This Year
$15.04
N/A
Revenue Next Year
$5.88
N/A
P/E Ratio
$80.97
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.38
$2.54
52 Week High
$65.69
$7.18

Technical Indicators

Market Signals
Indicator
ASTE
ANNX
Relative Strength Index (RSI) 34.62 41.79
Support Level N/A $3.71
Resistance Level $42.79 $4.36
Average True Range (ATR) 1.36 0.25
MACD 0.09 0.05
Stochastic Oscillator 17.75 52.00

Price Performance

Historical Comparison
ASTE
ANNX

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: